Evidence map›Paper›PMID 38896625›Full record

ArticleScience advances2024

Development of a nanoparticle-based tendon-targeting drug delivery system to pharmacologically modulate tendon healing.

Emmanuela Adjei-Sowah, Indika Chandrasiri, Baixue Xiao, Yuxuan Liu, Jessica E Ackerman, Celia Soto, Anne E C Nichols, Katherine Nolan, Danielle S W Benoit, Alayna E Loiselle

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Spatial transcriptomic applications in orthopedics.Connective tissue research · 2025
    Review
  9. Article
  10. Review
  11. Pharmacological antagonism of Ccr2+ cell recruitment to facilitate regenerative tendon healing.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2025
    Article
  12. Article
  13. Loss ofMatrix biology plus · 2025
    Article
  14. Anti-inflammatory therapy for tendinopathy usingFrontiers in bioengineering and biotechnology · 2025
    Article
  15. Article
  16. Loss ofbioRxiv : the preprint server for biology · 2024
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Emmanuela Adjei-SowahDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.ORCID 0000-0002-0219-043X
Indika ChandrasiriDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.
Baixue XiaoDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.
Yuxuan LiuDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.
Jessica E AckermanCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-7900-2321
Celia SotoCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0003-1787-3249
Anne E C NicholsCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY 14642, USA.ORCID 0000-0001-8754-7735
Katherine NolanDepartment of Comparative Medicine, University of Rochester Medical Center, Rochester, NY 14642, USA.
Danielle S W BenoitDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.ORCID 0000-0001-7137-8164
Alayna E LoiselleDepartment of Biomedical Engineering, University of Rochester, Rochester, NY 14623, USA.ORCID 0000-0002-7548-6653

Funding

The University of Rochester's Clinical and Translational Science InstituteUL1TR002001 · NCATS · UNIVERSITY OF ROCHESTER · PI WILSON, KAREN M., ZAND, MARTIN S · 2016 to 2024
$34.6M
Modulating Cell-fate to Promote Regenerative Tendon HealingR01AR077527 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2021 to 2025
$2.0M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Tendon TRAP: Targeted Therapeutic Delivery to Enhance Tendon HealingR21AR081063 · NIAMS · UNIVERSITY OF ROCHESTER · PI BENOIT, DANIELLE S., LOISELLE, ALAYNA · 2022 to 2023
$373k
Molecular Multispectral ImagingS10RR026542 · NCRR · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A · 2010 to 2010
$370k
NCATS NIH HHS UL1 TR002001NCRR NIH HHS S10 RR026542NIAMS NIH HHS R01 AR073169NIAMS NIH HHS R01 AR077527NIAMS NIH HHS R21 AR081063
6 · The paper itself

Abstract

Satisfactory healing following acute tendon injury is marred by fibrosis. Despite the high frequency of tendon injuries and poor outcomes, there are no pharmacological therapies in use to enhance the healing process. Moreover, systemic treatments demonstrate poor tendon homing, limiting the beneficial effects of potential tendon therapeutics. To address this unmet need, we leveraged our existing tendon healing spatial transcriptomics dataset and identified an area enriched for expression of

Indexed as

Tendon InjuriesTendonsWound HealingAnimalsCalcium-Binding ProteinsDisease Models, AnimalDrug Delivery SystemsHumansMiceNanoparticle Drug Delivery SystemNanoparticlesCalcium-Binding ProteinsNanoparticle Drug Delivery System

Identifiers

PMID38896625
PMCPMC11186494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.